Sarcoma Awareness Month: Unpacking the Complexities and Emerging Hope of Immunotherapy
admin Sarcoma, a rare and notably complex group of cancers, has historically presented significant therapeutic challenges,...
Immunotherapy & CAR-T Research
Cancer Research Institute Unveils 2026 Lloyd J. Old STARs, Committing $6.25 Million to Propel High-Risk, High-Reward Immunotherapy Innovations.
The Cancer Research Institute (CRI) has officially announced the five distinguished recipients of its 2026...
Drs. Ken Murphy and Crystal Mackall on the ‘Long Game’ Behind Cancer Breakthroughs
At the highly anticipated 2026 AACR Annual Meeting, a beacon event in the global cancer...
The Unseen Foundation: Illuminating the Relentless Dedication Behind Cancer Breakthroughs
Long after the sun has set, casting the world into darkness, a solitary glow emanates...
Two Stage 4 Melanoma Survivors Share a Journey of Scientific Breakthrough, Enduring Hope, and the Profound Value of Ordinary Life
The rhythmic hum of daily life – the morning rush to school, the methodical push...
A Promise Made, A Promise Kept: Meet the Inaugural CRI IGNITE Fellows
In a landmark announcement in October 2025, the Cancer Research Institute (CRI) unveiled the IGNITE...
The Cancer Research Institute’s Third Annual Bioinformatics Bootcamp Empowers Next Generation of Immunotherapy Researchers
From May 16 to 22, 2026, over 50 fellows and students converged at the prestigious...
Cancer Research Institute Announces 2026 Recipients of Highest Scientific Honors in Cancer Immunotherapy
The Cancer Research Institute (CRI), a global leader in advancing immunotherapy, proudly announces the recipients...
Nobel Laureate Susumu Tonegawa, Pioneer of Immunological Diversity and Neuroscience, Dies at 86
The scientific community mourns the loss of Susumu Tonegawa, PhD, a towering figure in molecular...
Legacy of Hope: How Planned Giving to the Cancer Research Institute Propels Immunotherapy Towards a Cancer-Immune World
Including the Cancer Research Institute (CRI) in one’s will represents a profound personal commitment to...
